<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02739958</url>
  </required_header>
  <id_info>
    <org_study_id>R/16.01.112</org_study_id>
    <nct_id>NCT02739958</nct_id>
  </id_info>
  <brief_title>Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx</brief_title>
  <official_title>Effects of Propofol-dexmedetomidine on Immune Function During Total Laryngectomy Surgery Compared With Isoflurane Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, randomized clinical study is to compare between propofol and&#xD;
      isoflurane on perioperative immune cell populations and function in patients undergoing total&#xD;
      laryngectomy surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The perioperative period might be a critical time in primary cancer surgery because many&#xD;
      factors can affect whether recurrence, or metastasis , or elimination by the immune system.&#xD;
&#xD;
      Cancer surgery can induce an acute inflammatory response, due to local tissue damage and the&#xD;
      shedding of malignant cells into the blood and lymphocytic circulation although meticulous&#xD;
      surgical manipulation. Many evidences suggest that several factors during the perioperative&#xD;
      period can affect the immune system.&#xD;
&#xD;
      These could be attributed to the surgery per se, pain, anxiety, hypothermia, blood&#xD;
      transfusion, anesthetic technique, and anesthetic drugs .Impairment in the immune system may&#xD;
      allow malignant cells to escape immuno-surveillance and metastasize in the perioperative&#xD;
      period.As well as increase the risk of postoperative complications, such as systemic&#xD;
      inflammatory response syndrome, sepsis, and multi-organ failure.&#xD;
&#xD;
      Previous retrospective clinical studies of both breast and prostate cancer surgery have&#xD;
      suggested an association between anaesthetic technique and cancer recurrence.&#xD;
&#xD;
      However ,other retrospective trials on various forms of cancer have shown no such benefit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2016</start_date>
  <completion_date type="Actual">October 30, 2016</completion_date>
  <primary_completion_date type="Actual">August 30, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CD3 plasma level</measure>
    <time_frame>for 7 days after procedure</time_frame>
    <description>Venous blood samples will be collected. The extracted venous blood samples will be mixed evenly in a special anti-coagulation test tube and stored in a refrigerator (at 4C).Flow cytometer will be used to detect the level of CD3+</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>for 5 hours during the procedure</time_frame>
    <description>Intraoperative heart rate changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>for 5 hours during the procedure</time_frame>
    <description>Intraoperative blood pressure changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral oxygen saturation measured with pulse oximetry</measure>
    <time_frame>for 5 hours during the procedure</time_frame>
    <description>Intraoperative peripheral oxygen saturation changes as measured with pulse oximetry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cancer Larynx</condition>
  <condition>Total Laryngectomy</condition>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive only intravenous anesthetics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isoflurane group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive isoflurane /fentanyl anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol group</intervention_name>
    <description>Anesthesia is maintained with continuous infusion of propofol 1.5-2mg/kg/h and dexmedetomidine 0.2-1ug/kg/h.</description>
    <arm_group_label>Propofol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane group</intervention_name>
    <description>Anesthesia was maintained with isoflurane at a concentration of 2-2.5%. fentanyl 50 ug increments</description>
    <arm_group_label>Isoflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status I- III&#xD;
&#xD;
          -  Scheduled for total laryngectomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients refusal.&#xD;
&#xD;
          -  Morbid obese patients (body mass index &gt;40 kg/m2).&#xD;
&#xD;
          -  Allergy to local anesthetics agents used.&#xD;
&#xD;
          -  Severely altered consciousness level.&#xD;
&#xD;
          -  Psychiatric disorders.&#xD;
&#xD;
          -  Severe or uncompensated cardiovascular disease.&#xD;
&#xD;
          -  Severe renal disease.&#xD;
&#xD;
          -  Severe hepatic disease.&#xD;
&#xD;
          -  Severe endocrinal diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reem A El Sharkawy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Hospitals, Ear Nose Thorat Department, Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 11, 2016</study_first_submitted>
  <study_first_submitted_qc>April 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

